Results 201 to 210 of about 502,861 (219)

The immune landscape of common CNS malignancies: implications for immunotherapy

Nature Reviews Clinical Oncology, 2021
Robert M. Prins, Amy B. Heimberger, Martina Ott   +2 more
exaly  

Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis

Nature Medicine, 2021
Juliane Gust, Michael C Jensen, Wenjun Huang   +2 more
exaly  

CNS border-associated macrophages in the homeostatic and ischaemic brain

Pharmacology & Therapeutics, 2022
Alexandra Riddell
exaly  

CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials

Annals of Oncology, 2018
James Chih-Hsin Yang, Enriqueta Felip, M-J Ahn   +2 more
exaly  

Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery

ACS Chemical Neuroscience, 2012
Arup K Ghose, Robert L Hudkins, John P Mallamo   +2 more
exaly  

Nanotechnology—novel therapeutics for CNS disorders

Nature Reviews Neurology, 2012
John A Kessler
exaly  

The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes

Neuropharmacology, 2017
Leonard K Kaczmarek, Valentin K Gribkoff
exaly  

Plant sterols: Friend or foe in CNS disorders?

Progress in Lipid Research, 2015
Jo Mailleux, Jeroen F J Bogie, Jerome Hendriks   +2 more
exaly  

The Gut–CNS Axis in Multiple Sclerosis

Trends in Neurosciences, 2020
Francisco J. Quintana
exaly  

Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties

ACS Chemical Neuroscience, 2010
Travis T Wager, Xinjun Hou, Patrick R Verhoest   +2 more
exaly